FINancial Toxicity and CAncer REcovery in YOUNG Adults

NCT ID: NCT07314801

Last Updated: 2026-01-02

Basic Information

• Recruitment Status: ENROLLING_BY_INVITATION
• Total Enrollment: 300 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2025-12-31
• Study Completion Date: 2026-04-30

Brief Summary

The FINCARE-Young study aims to investigate the extent and development of financial toxicity in adolescents and young adults with cancer. The primary purpose of this study is to assess the level of financial burden experienced during the acute phase of cancer treatment and after completion of therapy, and to analyze changes over time. In addition, the study seeks to identify sociodemographic, clinical, and socioeconomic factors associated with financial toxicity, as well as its impact on employment and social reintegration. By focusing on young adult cancer survivors, this study addresses an underexplored population and seeks to generate evidence to improve supportive care strategies and reduce long-term financial consequences of cancer.

Conditions

Financial Toxicity Related to Cancer Diagnosis and Tretment in Adolescents and Young Adults

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: CROSS_SECTIONAL

Study Groups

Adolescents and Young Adults with Cancer

This cohort consists of adolescents and young adults aged 18 to 39 years at the time of initial cancer diagnosis who received oncological treatment at a single tertiary care center. Participants have completed their primary cancer therapy and are assessed retrospectively and prospectively. The study does not involve any therapeutic intervention. Data are collected through structured telephone interviews and standardized questionnaires, complemented by clinical data extracted from electronic medical records. The focus of the cohort is to evaluate financial toxicity, socioeconomic factors, and employment-related outcomes following cancer treatment.

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• Age 18 to 39 years at the time of initial cancer diagnosis
• Diagnosis of a malignant neoplasm
• Receipt of oncological treatment at the University Medical Center Göttingen
• Completion of primary cancer therapy at the time of study participation
• Initial diagnosis between 2014 and 2024
• Ability to provide informed consent
• Sufficient German language skills to participate in a telephone interview and complete questionnaires

Exclusion Criteria

• Age below 18 years or above 39 years at the time of initial cancer diagnosis
• No history of malignant disease
• Ongoing primary cancer treatment at the time of study participation
• Severe cognitive impairment or psychiatric condition preventing reliable participation
• Insufficient German language proficiency to complete interviews or questionnaires
• Withdrawal of informed consent

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 50 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University Medical Center Goettingen

OTHER

Sponsor Role: lead

Responsible Party

Prof. Dr. Rami El Shafie

Prof. Dr.

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Rami El Shafie, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

University Medicine Göttingen

Locations

University Medicine Göttingen

Göttingen, Lower Saxony, Germany

Countries

Germany

Other Identifiers

20/7/25

Identifier Type: -

Identifier Source: org_study_id